Skip to main content
TipRanks
Go Ultimate75% OFF

Vectorite Biomedical, Inc. (4170) Balance Sheet

Vectorite Biomedical, Inc. Balance Sheet

Vectorite Biomedical, Inc.'s total assets for Q2 2026 were NT$538.02M, an increase of 5.59% from the previous quarter. TW:4170 total liabilities were NT$26.99M for the fiscal quarter, a 10.24% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 509.56MNT$ 412.78MNT$ 452.10MNT$ 465.82MNT$ 492.64M
NT$ 24.48MNT$ 23.20MNT$ 21.25MNT$ 24.49MNT$ 25.71M
NT$ 485.08MNT$ 389.58MNT$ 430.85MNT$ 441.34MNT$ 466.94M

Currency in TWD

Vectorite Biomedical, Inc. Liabilities to Assets

0250M500M750M0 %15 %30 %45 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets